Lv23
164 积分 2025-12-22 加入
Osimertinib after definitive CRT in unresectable stage III EGFR-mutated NSCLC: safety outcomes from the phase III LAURA study
23小时前
求助中
Aumolertinib with or without chemotherapy in EGFR-mutated advanced non-small-cell lung cancer (AENEAS2): an open-label, multicentre, randomised, controlled, phase 3 trial
23小时前
已完结
M1-Polarized Macrophage Exosome Biomimetic Nanozyme Bioreactor for Nanozyme-Based Catalytic Tumor Therapy
3个月前
已完结
Tertiary lymphoid structure formation induced by LIGHT-engineered and photosensitive nanoparticles-decorated bacteria enhances immune response against colorectal cancer
3个月前
已完结
Tertiary lymphoid structures in anticancer immunity
3个月前
已完结
T Peripheral Helper Cells in Lymphoid Aggregate and Tertiary Lymphoid Structure Formation
3个月前
已完结
Biomimetic Macrophage Membrane and Lipidated Peptide Hybrid Nanovesicles for Atherosclerosis Therapy
3个月前
已完结
Minimally Invasive Distal Metatarsal Diaphyseal Osteotomy (MIS-DMDO) for the Prevention and Treatment of Chronic Plantar Diabetic Foot Ulcers
4个月前
已完结
A Real‐World Phase IV Superiority Trial and Cost‐Effectiveness Analysis of the Addition of Low‐Dose Nivolumab to Triple Metronomic Chemotherapy Compared to the Paclitaxel Carboplatin Regimen in Recurrent or Metastatic Head and Neck Cancer Patients
5个月前
已完结
Glycitein: A Comprehensive Review of its Bioactivities, Molecular Mechanisms, and Therapeutic Potential
5个月前
已完结
皖公网安备34019202002308
